Characteristics of functional bowel disorder patients: a cross-sectional survey using the Rome III criteria. (Q48390672)

11 February 2018

title

Characteristics of functional bowel disorder patients: a cross-sectional survey using the Rome III criteria. (English)

1 reference

11 February 2018

functional colonic disease

main subject

patient

0 references

1 reference

1

1 reference

11 February 2018

Paul Moayyedi

6

1 reference

11 February 2018

author name string

P Bercik

2

1 reference

11 February 2018

D G Morgan

3

1 reference

11 February 2018

C Bolino

4

1 reference

11 February 2018

M I Pintos-Sanchez

5

1 reference

11 February 2018

language of work or name

English

0 references

publication date

5 December 2013

1 reference

11 February 2018

Alimentary Pharmacology & Therapeutics

published in

1 reference

11 February 2018

volume

39

1 reference

11 February 2018

issue

3

1 reference

11 February 2018

page(s)

312-321

1 reference

11 February 2018

Functional bowel disorders

cites work

1 reference

Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis

21 January 2018

1 reference

Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis

21 January 2018

1 reference

U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact

21 January 2018

1 reference

Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire

21 January 2018

1 reference

Natural history of functional gastrointestinal disorders: comparison of two longitudinal population-based studies

21 January 2018

1 reference

Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome

21 January 2018

1 reference

Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care

21 January 2018

1 reference

The hospital anxiety and depression scale

21 January 2018

1 reference

The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms

21 January 2018

1 reference

The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study

21 January 2018

1 reference

Abdominal pain is associated with anxiety and depression scores in a sample of the general adult population with no signs of organic gastrointestinal disease

21 January 2018

1 reference

Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin

21 January 2018

1 reference

Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.

21 January 2018

1 reference

Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome--results of two randomized, placebo-controlled studies.

21 January 2018

1 reference

Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis

21 January 2018

1 reference

Efficacy of linaclotide for patients with chronic constipation

21 January 2018

1 reference

A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation

21 January 2018

1 reference

Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis

21 January 2018

1 reference

Randomized clinical trial: macrogol/PEG 3350 plus electrolytes for treatment of patients with constipation associated with irritable bowel syndrome

21 January 2018

1 reference

Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome.

21 January 2018

1 reference

Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhea.

21 January 2018

1 reference

Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome.

21 January 2018

1 reference

Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome

21 January 2018

1 reference

Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea

21 January 2018

1 reference

Randomised clinical trial: The ileal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation--a double-blind study

21 January 2018

1 reference

A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation

21 January 2018

1 reference

Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

Use of serum biomarkers in a diagnostic test for irritable bowel syndrome.

21 January 2018

1 reference

Serum and colonic mucosal immune markers in irritable bowel syndrome

21 January 2018

1 reference

Abnormal immune regulation and low-grade inflammation in IBS: does one size fit all?

21 January 2018

1 reference

A multidimensional model of psychobiological interactions in functional dyspepsia: a structural equation modelling approach

21 January 2018

1 reference

Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/APT.12573

1 reference

11 February 2018

1 reference

11 February 2018